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Background: After the application of chest computed tomography (CT), ground glass opacity
(GGO) was introduced as one of major accompanying findings of miliary tuberculosis (MT) in
addition to miliary nodules. However, little is known about whether GGO is associated with
the clinical manifestations and outcomes of MT. Therefore, the present study examined the
clinical relevance of GGO in patients with MT.
Methods: Chest radiographs and CT scans of MT patients were retrospectively reviewed. Clinical
manifestations and outcomeswere compared in terms of the extent of GGO revealed by chest CT.
Results: Confirmed 105 MT patients were included. GGO was observed in 70 (67%) patients. MT
patients with an extent of GGO>50% (nZ 21) had symptoms of shorter duration, more frequent
dyspnea, and more pronounced changes in the levels of acute phase reactants. Miliary nodules
were less discernible on CT in those with an extent of GGO >50%. MT patients with an extent
of GGO>50% were significantly associated with a longer hospital stay (pZ 0.02) and with acute
respiratory failure (p< 0.001) than thosewith anextent ofGGO50%.However,mortality among
MT patients was not associated with the extent of GGO.
Conclusion: MT patients with an extent of GGO >50% had more rapidly progressive manifesta-
tions and a greater potential for delayed diagnosis and poorer prognosis. Nevertheless, mortality
was not higher in confirmedMT patients with an extent of GGO>50% than in those with an extent
of GGO 50%.
ª 2014 Elsevier Ltd. All rights reserved.t of Internal Medicine, Kyungpook National University, School of Medicine, 680 Gukchaebosang-ro,
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Miliary tuberculosis (MT) results from massive lymphohe-
matogenous dissemination of Mycobacterium tuberculosis
(MTB) during both primary and post-primary tuberculosis
(TB) [1,2]. Despite the availability of effective treatments,
mortality remains high. The clinical manifestations range
from a rapidly progressive course to a slow and prolonged
course with subtle clinical findings [2e4].
Findings of a classic miliary pattern on chest radiography
provide an important clue when making a diagnosis of MT;
however, initial chest radiographs often show a non-classic
pattern or they can even be normal [5]. Thus, some pa-
tients with MT represent a diagnostic challenge. Chest
computed tomography (CT) is more helpful and enables the
early recognition of MT, even in patients with atypical or
normal findings on chest radiography. Therefore, patients
with suspected miliary nodules often undergo a chest CT.
After the application of chest CT, several studies reported
that ground glass opacity (GGO) was one of major accom-
panying findings of MT in addition to miliary nodules [6e9].
However, little is known about whether the extent of GGO
is associated with the clinical manifestations and outcomes
of these patients.
Therefore, the aim of the present study was to examine
the clinical relevance of GGO in patients with MT. In addi-
tion, because a previous study noted that some MT patients
had larger nodules in the lung apices than in the lung bases
[6], we also identified these patients and described their
clinical characteristics.Materials and methods
Patients
The study was conducted at Kyungpook National University
Hospital, a tertiary referral hospital in South Korea set in an
area with an intermediate prevalence of active TB (149
cases per 100,000 population in 2011) [10]. All MT patients
(aged  15 years) attending the hospital from April, 2001 to
December, 2012 were retrospectively selected using ICD-10
code A190-A199. Those with available chest radiographs
and CT scans were enrolled. Details regarding patient de-
mographics, clinical manifestations, risk factors (e.g.,
human immunodeficiency virus (HIV) infection, malignancy,
diabetes mellitus, immunosuppressive drug therapy, solid
organ transplantation, end-stage renal disease, chronic
liver disease, gastrectomy, alcoholism, or pregnancy),
laboratory and microbiological data, histological data (if
available), hospital course (initial admitting department,
time from admission to the start of anti-tuberculous
treatment, length of hospital stay, occurrence of respira-
tory failure, and the use of mechanical ventilation), and in-
hospital mortality were obtained from the medical records.
A final diagnosis was made in those patients suspected of
having MT on the basis of clinical and radiographic exami-
nations when a respiratory specimen or non-respiratory
specimen (tissue other than lung or urine) was found to
be culture-positive for MTB, or when there was histological
evidence of chronic granulomatous inflammation and thetissue was positive for the acid fast bacilli (AFB) test or TB-
polymerase chain reaction (PCR).
The study was approved by the Institutional Review
Board of the Kyungpook National University Hospital.Chest radiography and CT findings
Chest radiography and CT scans performed on admission
were retrospectively reviewed by one board-certified
radiologist and two board-certified pulmonologists who
were blinded to the patient’s clinical data. The initial chest
radiographs and CT scans were obtained within 3 days of
each other (median 0 day [interquartile range (IQR), 0-1]).
Chest CT scans were performed with two multidetector CT
scanners (LightSpeed, General Electric Medical Systems,
Milwaukee, WI, USA; Aquilion 64, Toshiba Medical Systems,
Otawara, Japan). Continuous axial images were obtained
with 2.5 mm or 3 mm collimation from the lung apices to
the bases at full inspiration. Images were reconstructed
using a high spatial frequency (bone) algorithm and pho-
tographed in the mediastinal (window width, 350e240 H;
level, 15e25 H) and lung windows (window width, 1500 H;
level, 600 to 800 H).
The investigators independently assessed the pattern of
the miliary lesions (classic miliary vs. non-classic miliary) on
chest radiographs and the presence of miliary nodules
(recognizable vs. non-recognizable) suggestive of MT on CT
scans. A “classic” miliary pattern was defined as a collec-
tion of tiny discrete pulmonary opacities that were gener-
ally uniform in size and widespread in distribution, each of
which measured 3 mm in diameter [2]. A “non-classic”
miliary pattern was defined as the obscuring of background
miliary nodules by diffuse GGO or the major findings char-
acterized by an asymmetric nodular pattern, coalesced
nodules, a mottled appearance, a snowstorm appearance,
or air-space consolidation [2]. On chest CT, recognizable
miliary nodules were defined when randomly distributed
micro-nodules were well discernible on chest CT. By
contrast, non-recognizable miliary nodules were defined
when micro-nodules could not be clearly discernible on
chest CT as the micro-nodules were superimposed on a
background of other radiologic findings, such as GGO.
However, patients in the latter group showed miliary nod-
ules on short-term follow-up chest radiographs and/or CT
scans taken after the other radiologic findings have
resolved. The extent of GGO observed on chest CT was
categorized as follows: 1) none; 2) less than one-quarter of
the whole lung field; 3) less than one-half of the whole lung
field but greater than one-quarter of the field; 4) greater
than one-half of the whole lung field [7]. The zonal prom-
inence (upper vs. even) of the nodules in size (when viewed
along the cephalocaudal axis) was estimated by comparing
the size of the miliary nodules at two levels of the chest CT
scan: the upper end of the aortic arch and the lower end of
the left atrium. Pre-existing active TB lesions, cavities,
pleural effusion, nodules 4 mm in diameter, and medias-
tinal lymphadenopathy were comprehensively examined. A
final decision on the findings was reached when the
consensus of two observers was obtained (JL and JKL). A
third observer (CHK) gave the final assessment if consensus
could not be reached.
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Statistical analyses were performed using SPSS software
(version 18.0; SPSS Inc., Chicago, Ill). Each data set was
tested for normality and equality of variances by means of
the ShapiroeWilk’s test and Levene’s test. Data with
skewed distribution was analyzed after logarithmic trans-
formation. Normal variables were expressed as the
mean  SD and analyzed using one-way ANOVA. For non-
normal variables, medians were presented with IQR and
KruskaleWallis test was used to compare differences
among groups. Categorical variables were expressed as
numbers and percentages and were analyzed using the c2
test or Fisher’s exact test. A p value of 0.05 was considered
significant.
Results
One hundred and thirty-two MT patients with available
chest radiographs and CT scans were identified. Of these,
clinically diagnosed (n Z 11) and HIV-positive (n Z 10)
patients were excluded. Six patients who showed chronic
granulomatous inflammation in the biopsy specimen
without a positive AFB smear or TB-PCR result were also
excluded. One hundred and five patients were microbio-
logically or histologically diagnosed with MT: 96 (91%) ac-
cording to a positive MTB culture (sputum or bronchoscopic
washing fluid [n Z 84], urine [n Z 6], pleural fluid [2],
spine tissue [nZ 2], transbronchial lung tissue [nZ 2]) and
9 (9%) according to histological results (chronicTable 1 Comparison of clinical features according to the exten
tuberculosis.
Clinical features Total
(n Z 105)
Ground glass opacity
One (n Z 35) <25%
Age, years
<65 53 (50) 23 (66) 11 (39
65 52 (50) 12 (34) 17 (61
Male 50 (48) 17 (49) 14 (50
Risk factorsa 33 (31) 12 (34) 8 (29)
Symptom
duration, day
30 (16e59) 30 (21e60) 30 (20
Weakness 92 (88) 29 (83) 27 (96
Weight loss 76 (73) 26 (74) 22 (79
Fever 80 (76) 28 (80) 19 (68
Cough 60 (57) 21 (60) 14 (50
Dyspnea 37 (35) 6 (17) 6 (21)
WBC, cells/mL 6620 (5260e8760) 6530 (5390e7770) 6870
CRP, mg/dL 8.0 (3.3e12.2) 3.8 (1.0e6.7) 8.4 (3
Albumin, g/dL 2.9  0.61 3.3  0.58 3.0 
SpO2 on room air, % 96 (90e98) 97 (96e98) 97 (93
Sputum AFB
smear (þ)c
27/82 8/26 4/22
Data are expressed as the number (%), mean  SD, or median (IQR).
CT Z computed tomography; WBC Z white blood cell; CRPZC-re
AFB Z acid fast bacilli.
a Including malignancy, diabetes mellitus, immunosuppressive drug
disease, gastrectomy, alcoholism, or pregnancy.
b Becomes non-significant after correction for the number of compa
c Positive number/performed number.granulomatous inflammation with positive AFB smear
(n Z 4) or TB-PCR (n Z 5) results in tissue). Chest CT
identified GGO in 70 (67%) patients. The extent of GGO was
variable: none (nZ 35), <25% (nZ 28), 25e50% (n Z 21),
and >50% (n Z 21). Whereas miliary nodules were uni-
formly distributed throughout both lungs, GGO was pre-
dominant in the lower lung zones.
Comparison of clinical features according to the
extent of GGO on chest CT
There were no significant differences in the age distribution
(according to a median of 64 years old), gender, or risk
factors between groups showing a different extent of GGO
on chest CT (Table 1). Patients with an extent of GGO >50%
had symptoms of shorter duration prior to first presentation
than those with an extent of GGO 50% (pZ 0.037). There
were no differences in constitutional symptoms and signs,
including fever, between the groups. However, the number
of patients reporting dyspnea increased proportionally with
the extent of GGO (p < 0.001). Patients with an extent of
GGO >50% reported dyspnea more frequently; indeed,
these patients showed lower oxygen saturation on room air
(p < 0.001). Although there were no differences in the
white blood cell (WBC) count among the groups, C-reactive
protein (CRP) increased and albumin levels decreased in
patients with more extensive GGO (p < 0.001 and
p Z 0.003, respectively). There was no significant differ-
ence in the number of AFB smear-positive sputum samples
among the groups.t of ground glass opacity on chest CT in patients with miliary
(n Z 28) 25e50% (n Z 21) >50% (n Z 21) P value
) 8 (38) 11 (52) 0.113
) 13 (62) 10 (48)
) 9 (43) 10 (48) 0.966
6 (29) 7 (33) 0.950
e60) 30 (15e45) 19 (14e33) 0.037b
) 17 (81) 19 (91) 0.268
) 11 (52) 17 (85) 0.108
) 16 (76) 17 (81) 0.656
) 11 (52) 14 (67) 0.643
9 (43) 16 (76) <0.001
(5970e9120) 7230 (4203e8873) 6450 (4773e10475) 0.891
.1e14.5) 9.3 (5.9e17.6) 9.6 (6.1e14.8) <0.001
0.53 2.9  0.54 2.7  0.60 0.003
e98) 95 (93e97) 82 (68e91) <0.001
7/16 8/18 0.510
active protein; SpO2 Z oxygen saturation by pulse oximetry;
therapy, transplantation, end-stage renal disease, chronic liver
risons.
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the extent of GGO on chest CT
A classic miliary pattern was observed on chest radio-
graphs in 54 (51%) of the 105 patients (Table 2). Seven (7%)
patients who had normal findings on initial chest radio-
graphs but who had a fever of unknown origin (n Z 3),
unexplained shortness of breath (n Z 2), or developed
new abnormal findings on follow-up chest radiographs
(n Z 2) were examined by a chest CT. However, a signif-
icant number of patients with an extent of GGO >50% (18/
21, 86%; p < 0.001) did not show a classic miliary pattern
on chest radiography. Chest CT identified miliary nodules
in 91 (87%) of the 105 MT patients. Chest CT revealed
findings suggestive of MT in all but one of the patients with
an extent of GGO 50%, even though the chest radio-
graphs showed a non-classic miliary pattern or were
normal. One patient (with an extent of GGO of 25e50% and
non-classic miliary findings on chest radiography) did not
have miliary nodules on initial chest CT; however, miliary
nodules were identified on follow-up chest radiographs
and CT scans performed 7 days later and diagnosed with
MT by a transbronchial lung biopsy. By contrast, 13 (62%)
of the 21 patients with an extent of GGO > 50% were not
suspected of having MT on initial chest CT. Thus, the
number of inaccurate diagnoses based on the initial CT
scan was significantly higher in this patient group
(p < 0.001). A later diagnosis of MT was made in these
patients (median delay before diagnosis was 4 days [IQR,
1e17]) when further evidence of TB (i.e., positive results
for AFB smear, TB-PCR, or histology) and typical radio-
graphic findings of MT with the resolution of GGO on sub-
sequent chest radiographs and/or CT scans appeared. Pre-
existing active lung lesions were observed in 52 (50%) pa-
tients. There were no significant differences in the inci-
dence of the pre-existing active TB lesions, cavities,
pleural effusion, and mediastinal lymphadenopathy be-
tween the groups.
The lung nodules in 76 (72%) patients were approxi-
mately the same size and shape; however, in 29 (28%) pa-
tients, the apical nodules were larger than the basal
nodules (Fig.1). The number of patients with larger nodules
in the upper lung field was significantly different between
the four groups (p Z 0.002) (Table 2). The proportion of
patients with upper-prominent or evenly-sized nodules wasFigure 1 Chest CT in a 27-year-old man. CT scans at two levels sho
the upper lobes (left) are larger than those in the lower lobes (rigsimilar in the non-GGO group whereas the proportion of
patients with evenly-sized nodules was higher in the GGO
groups. Most of the nodules measured 1e3 mm in diameter;
however, nodules 4 mm in diameter, irrespective of the
extent of GGO, were present in eight (8%) patients.
Comparison of clinical outcomes according to the
extent of GGO on chest CT
Although the mean time from admission to the start of anti-
tuberculosis treatment and the number of patients with
delay of greater than 3 days to diagnosis increased pro-
portionally with the extent of GGO, the differences were
not statistically significant. Acute respiratory failure
occurred significantly more often in the group with an
extent of GGO >50% (p < 0.001) (Table 3). Seven patients in
this group suffered acute respiratory failure that man-
ifested as acute respiratory distress syndrome (ARDS). No
cases of ARDS were identified in the other groups. The
length of hospital stay for the surviving patients was
significantly longer in the group with an extent of GGO
>50% (pZ 0.024). However, there was no difference in in-
hospital mortality (10% overall) between the groups.
Comparison of clinical and radiological findings
according to the prominence of nodules on chest
CT
Patients with upper-prominent nodules experienced symp-
toms of longer duration than those without (54  43 vs.
36  32 days, respectively; p Z 0.018). They also showed
higher oxygen saturation on room air (94  5.6 vs.
89  15.0%, respectively; p Z 0.047). There were no sig-
nificant differences in terms of age distribution, gender,
risk factors, frequency of clinical signs and symptoms, WBC,
or albumin levels between the upper-prominent and non-
prominent groups. The patients with upper-prominent
nodules showed a significantly lower incidence of GGO on
CT than those without (12/29 [41%] vs. 58/76 [76%],
respectively; p Z 0.001) (Table 2). All eight patients with
nodules measuring 4 mm in diameter belonged to the
group with upper-prominent nodules (28 vs. 0%, p < 0.001).
However, there was no difference in clinical outcomes
including mortality between both groups.w numerous small nodules 1e5 mm in diameter. The nodules in
ht).
Table 2 Comparison of radiologic features according to the extent of ground glass opacity on chest CT in patients with miliary
tuberculosis.
Radiologic features Total
(n Z 1 05)
Ground glass opacity
None (n Z 35) <25% (n Z 28) 25e50% (n Z 21) >50% (n Z 21) P value
Chest X-ray pattern
Classic miliary 54 (51) 21 (60) 15 (54) 15 (71) 3 (14) <0.001
Non-classic miliary 44 (42) 10 (29) 10 (36) 6 (29) 18 (86)
Negative 7 (7) 4 (11) 3 (11) 0 (0) 0 (0)
Chest CT findings
Miliary nodules
Recognizable 91 (87) 35 (100) 28 (100) 20 (95) 8 (38) <0.001
Non-recognizable 14 (13) 0 (0) 0 (0) 1 (5) 13 (62)
Preexisting active TB lesions 52 (50) 17 (49) 11 (40) 13 (62) 11 (52) 0.200
Cavity 24 (23) 8 (23) 8 (29) 4 (19) 4 (19) 0.875
Pleural effusion 32 (31) 7 (20) 9 (32) 7 (33) 9 (43) 0.327
Mediastinal lymphadenopathy 31 (30) 11 (31) 4 (14) 8 (38) 8 (38) 0.177
Prominence of nodules in size
Upper 29 (28) 17 (49) 5 (18) 6 (29) 1 (5) 0.002
Even 76 (72) 18 (51) 23 (82) 15 (71) 20 (95)
Nodules  4 mm in size 8 (8) 5 (14) 1 (4) 2 (10) 0 (0) 0.220
Data are expressed as the number (%).
CT Z computed tomography; TB Z tuberculosis.
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The present study classified MT according to the extent of
GGO. The results showed the following: 1) MT patients with
an extent of GGO >50% experienced symptoms for a shorter
time prior to admission and were more likely to suffer from
dyspnea than those with an extent of GGO 50%; 2) CRP
levels increased and albumin levels decreased in line with
the extent of GGO; 3) chest CT was suggestive of MT in 37
(73%) of 51 patients showing either a non-classic miliary
pattern or normal findings on chest radiography; however,
miliary nodules suggestive of MT were significantly more
difficult to visualize on chest CT in patients with an extent
of GGO > 50%; 4) upper-prominent miliary nodules were
observed in 28% of MT patients, and occurred more
frequently in patients without GGO than in those with GGO;
and 5) there was a significant increase in the length of
hospital stay and in the incidence of acute respiratory
failure in MT patients with an extent of GGO > 50%.
The clinical manifestations of MT comprise mainly non-
specific constitutional symptoms and signs, the most
notable being a persistent low-grade fever. Respiratory
symptoms are less common. In the present study, the fre-
quency of particular signs and symptoms was not signifi-
cantly different from that reported in previous studies
[4,11e16]. However, dyspnea (supported by the finding of
low oxygen saturation on room air) was one of major
symptoms in patients with an extent of GGO > 50%. The
shorter duration of symptoms prior to admission in these
patients may be due to the development of dyspnea, which
can limit daily activities and is more distressing than other
symptoms.
A miliary pattern on the chest radiographs is the hall
mark of MT and is often the first clue to diagnosis. However,
a classic miliary pattern is not evident on chest radiographsin up to 50% of patients [3,17,18]. The present study
showed a non-classic miliary pattern in 49% of MT patients.
The non-classic miliary patterns in these cases may be
attributed to pre-existing lung lesions and GGO. CT is su-
perior to chest radiography for evaluating chest-related
diseases. It can identify tiny nodules in even cases with
normal findings on chest radiography and define the
anatomic distribution of micro-nodules within the lungs
[7,8]; this is helpful for diagnosing MT characterized by
randomly distributed tiny nodules. Ninety-one (87%) pa-
tients in the present study were suspected of having MT
based on chest CT (Table 2). Thirteen (93%) of the
remaining 14 patients, of whom miliary nodules were not
discernible on chest CT, had an extent of GGO > 50%. In
contrast to chest radiography, pre-existing lung lesions
including cavity or consolidation on chest CT may be helpful
for the suspicion of MT in conjunction with miliary nodules.
However, extensive GGO makes the recognition of miliary
nodules difficult. Therefore, MT patients who were not
suspected of having MT even after the application of chest
CT are likely to be attributed to extensive GGO.
Two previous studies with 14 and 25 MT patients re-
ported the incidence of GGO as 64% and 92%, respectively
[7,9]. The present study showed that the incidence of GGO
in MT patients was 67%. GGO was not uniformly distributed
and it was transient, unlike miliary nodules uniformly
distributed and persisted several weeks even after treat-
ment. Thus, GGO is considered to represent a transient
exudative change [8]. We found that GGO was predominant
in the lower portion of the lung, reflecting the perfusion
gradient. Patients with an extent of GGO >50% had more
acute symptoms and showed more profound changes in the
levels of acute phase reactants such as CRP and albumin.
Some patients with extensive GGO developed ARDS. Thus,
extensive GGO in patients with MT may indicate a more
rapidly progressive form of MT. Differences in the extent of
Table 3 Comparison of clinical outcomes according to the extent of ground glass opacity on chest CT in patients with miliary
tuberculosis.
Clinical outcomes Total (nZ 105) Ground glass opacity
None (nZ 35) <25% (nZ 28) 25e50% (nZ 21) >50% (nZ 21) P value
Time to anti-TB treatment, day 1 (0e3) 1 (0e3) 1 (0e3) 1 (1e4) 2 (1e5) 0.653
Delay > 3 days to diagnosis 23 (22) 5 (14) 6 (21) 5 (24) 7 (33) 0.404
Acute respiratory failure 11 (10) 1 (3) 0 (0) 3 (14) 7 (33) <0.001
Hospital length of stay in survivor, day 15 (9e24) 13 (7e27) 15 (7e21) 15 (11e22) 22 (17e39) 0.024a
Mortality 11 (10) 2 (6) 3 (11) 3 (14) 3 (14) 0.670
Data are presented as the number (%) or median (IQR).
CT Z computed tomography; TB Z tuberculosis.
a Becomes non-significant after correction for the number of comparisons.
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individual differences in the inflammatory response to
disseminated tubercle bacilli. This type of response may
depend on interplay between mycobacterial virulence and
host immunity [19,20]. However, future study needs to be
done to fully explain why some MT patients develop
extensive GGO.
The present study confirmed that patients with exten-
sive GGO suffer more frequent episodes of dyspnea and
ARDS [7,8,21,22]. The length of hospital stay was signifi-
cantly greater for survivors with an extent of GGO > 50%. In
addition, it should be noted that 7 patients with delayed
anti-TB treatment and an extent of GGO >50% were initially
admitted in pulmonary department (Table 3). These find-
ings suggest that early diagnosis of MT in patients with
extensive GGO may be difficult in even experienced clini-
cians who are familiar with MT. Thus, clinicians should have
a high index of suspicion for MT when patients present with
extreme GGO or unexplained ARDS.
The present study examined the prominence of miliary
nodules in the cephalocaudal axis. Upper-prominent nod-
ules were noted in previous studies [7,23]. In some patients
with MT, the disease can be protracted rather than rapidly
progressive. [2,3] Gurney et al. [24] described that, in cases
of advanced MT, nodules at the lung apex are larger than
those at the base. The oxygen-rich environment in the
upper lung provides more favorable conditions for the
growth of MTB [25]. Thus, upper-prominent nodules may
suggest more advanced or protracted form rather than
rapidly progressive form with extensive GGO. To the best of
our knowledge, the incidence of upper-prominent nodules
in a large population of MT patients has not been examined
since the introduction of effective anti-TB drugs. The pre-
sent study identified upper-prominent nodules in 28% of MT
cases. These patients suffered symptoms of significantly
longer duration than those without, although the mortality
rate was the same for both groups (10%). In addition, eight
(28%) of these patients with upper-prominent nodules had
nodules 4 mm in diameter. Thus, this form of MT should be
considered in the differential diagnosis of pneumoconiosis
or hematogenous miliary metastasis showing variable sized
nodules. Fever and the presence of larger nodules in the
upper lungs may help to distinguish MT from other diseases
characterized by lung nodules of variable size.
The present study has several limitations. First, the
cohort included microbiologically- or pathologically-confirmed cases of MT. Many patients with MT are clini-
cally diagnosed. In addition, patients with extreme GGO
may have died from acute respiratory failure prior to
diagnosis. Thus, we may have underestimated the overall
incidence and mortality rate, particularly in patients with
an extent of GGO >50%. Second, we did not investigate the
long-term effect of GGO on patient outcomes. Third, the
present study included patients for whom chest radiographs
and CT scans were performed concurrently. However, this
does not mean that CT should be routinely recommended
for all patients suspected of having MT, unless the results of
chest radiography are atypical. Finally, certain multiplicity
problems may have resulted from the comparison of mul-
tiple parameters. However, all the significant findings
remained after correction for the number of comparisons
apart from symptom duration and hospital stay in survivors.
The corresponding variables need to be tested in further
confirmatory studies.
In conclusion, the present study systematically docu-
ments the clinical relevance of GGO in patients with MT and
additional information with respect to upper-prominent
nodules in the cephalocaudal axis. Patients with an extent
of GGO >50% had a more serious presentation and a greater
potential for delayed diagnosis and a poorer prognosis.
Nevertheless, the mortality was not greater in confirmed
MT patients with an extent of GGO >50% than in those with
an extent of GGO 50%.Conflict of interest
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